Tampulay, Teresa L.
HRN: 21-33-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2023
CEFTRIAXONE 1G (VIAL)
06/05/2023
06/12/2023
IV
2g
OD
CAP-MR; Presumptive PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes